HB 2677
In CommitteeHouse
Seizure detection devices
Requiring coverage for seizure detection devices as durable medical equipment under certain circumstances.
This status may be delayed. See Action History below for the latest updates.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill requires Washington’s Medicaid program to cover seizure detection devices and related services for eligible beneficiaries, starting January 1, 2026, if medically appropriate. It also updates existing medical assistance rules to clarify coverage for services like personal care, hospice, and mental health care — though most are contingent on available funding.
- Starting January 1, 2026, the state must cover seizure detection devices as durable medical equipment for Medicaid (medical assistance) beneficiaries, if deemed medically appropriate by a health care provider.
- Coverage includes the device itself and any related service or subscription (e.g., remote monitoring), with reimbursement for subscriptions set at 100% of the rate for monthly remote monitoring under the state’s telemonitoring benefit.
- The state must conduct a biennial review of covered seizure detection devices to ensure access to the latest FDA-approved technologies.
- The bill defines a seizure detection device as an FDA-approved device that detects seizures, alerts caregivers, and/or collects data to help diagnose or treat seizure-causing conditions.
- The bill clarifies that durable medical equipment means reusable equipment used for a medical purpose.
- The bill amends existing rules on medical assistance to reinforce that it includes services like personal care, hospice, mental health assessments for young children, and colorectal cancer screening — though many of these are subject to funding availability.
Who is affected
- People with seizure disorders (including children and adults) — Individuals with epilepsy or other conditions causing seizures who use or need seizure detection devices to monitor seizures and reduce risk of injury or death.
- Caregivers and family members — Families and caregivers of individuals with seizure disorders, who may receive alerts from the device and assist with medical response.
- Hospitals and health care providers — Hospitals and providers who must follow new billing rules for patients who are not meeting criteria for acute inpatient care but cannot be discharged due to lack of alternative placement.
- Medicaid recipients — Medicaid beneficiaries (including those in managed care), especially those receiving personal care services, hospice, mental health services, or colorectal cancer screening.
- Area agencies on aging and tribal health organizations — Area agencies on aging and federally recognized Indian tribes that may contract with the state to provide case management and reassessment for personal care services.
Pro/Con Analysis
Stronger case for benefits
Potential Benefits (5)
Mandating full coverage of seizure detection devices for Medicaid beneficiaries directly reduces out-of-pocket costs and improves safety for people with seizure disorders—especially children and adults with severe epilepsy—by preventing injury or sudden unexpected death in epilepsy (SUDEP), with strong clinical evidence supporting device efficacy.
HealthcarePeopleRef: Sec. 1(14)(a)(ii)(A)The requirement that devices be deemed 'medically appropriate' by a provider ensures clinical judgment guides coverage, reducing inappropriate use while still prioritizing need—this protects against overuse while expanding access for those who stand to benefit most.
HealthcarePeopleRef: Sec. 1(14)(a)(i)Coverage includes both the device and related subscription/service costs (e.g., remote monitoring), eliminating a major barrier to adoption—many patients currently forgo or discontinue devices due to ongoing subscription fees, so full coverage improves adherence and long-term health outcomes.
HealthcarePeopleRef: Sec. 1(14)(b)The provision preventing 'hospital hold' (patients stuck in acute care due to lack of post-acute placement) improves patient flow and reduces unnecessary institutionalization—though not universally implemented, it supports timely discharge and reduces the risk of hospital-acquired infections and functional decline.
HealthcarePeopleRef: Sec. 1(13)(a)Reimbursement for mental health assessments in home or community settings for children birth–5 increases access for families who lack transportation or face mobility barriers—this is especially critical for low-income and rural families, supporting early intervention and long-term developmental outcomes.
HealthcarePeopleRef: Sec. 1(11)(a)(ii)
Potential Concerns (5)
The bill creates a new hospital billing pathway for Medicaid patients who are clinically ready for discharge but lack available post-acute placement, potentially increasing state Medicaid costs without clear cost containment or quality safeguards—this may incentivize longer hospital stays and strain hospital finances, with limited direct benefit to patients beyond avoiding inappropriate admission denial.
HealthcarePeopleRef: Sec. 1(13)(a)The requirement to use the DC:0-5 diagnostic classification system for mental health assessment of young children may increase administrative burden on providers (especially in under-resourced areas), and the lack of guaranteed funding for this requirement (subject to appropriation) could lead to inconsistent implementation or provider non-participation, limiting access for children who need it.
HealthcareLean peopleRef: Sec. 1(11)(b)(ii)Coverage for seizure detection devices is tied to provider determination of medical appropriateness, which introduces clinical discretion that may lead to inconsistent access—especially for Medicaid beneficiaries in rural or underserved areas with fewer specialists—potentially widening disparities in device access despite the mandate.
HealthcarePeopleRef: Sec. 1(14)(a)(ii)(B)The biennial review of FDA-approved devices may increase long-term program costs as newer, more expensive devices are added, and without explicit cost controls or comparative effectiveness standards, the state could face rising expenditures with uncertain health outcomes—potentially diverting funds from other high-need services.
HealthcareLean peopleRef: Sec. 1(14)(c)Reimbursement for seizure detection subscriptions is capped at 100% of the existing telemonitoring rate, which may not reflect the true cost of newer or more sophisticated monitoring services—potentially discouraging device manufacturers or service providers from participating in Medicaid, limiting beneficiary access.
HealthcareLean peopleRef: Sec. 1(14)(b)
Who Is Most Affected
People with seizure disorders—especially those on Medicaid—gain direct health and safety benefits from device coverage, reducing injury risk and improving quality of life. However, access may still be limited by provider availability or rural service gaps.
Caregivers benefit from real-time alerts and reduced stress, but may face challenges if providers do not adequately train them on device use or if service coverage lags behind device updates.
Hospitals benefit from new billing authority for patients stuck in acute care, reducing financial risk from uncompensated care—but may face administrative complexity in implementing the new billing rules and coordinating with post-acute providers.
Medicaid recipients gain expanded coverage for personal care, hospice, mental health, and colorectal screening—but many of these services are explicitly contingent on funding availability, limiting guaranteed access.
Area agencies on aging and tribal health organizations gain expanded contracting opportunities for case management and reassessment—but must absorb administrative costs and may face staffing constraints if funding is insufficient.